Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT01473485
What this trial is testing

ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors

Who this might be right for
GliomaMetastatic Brain Cancer
InSightec 10
Early research (Phase 1)Study completedNCT01922076
What this trial is testing

Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaDiffuse Intrinsic Pontine Glioma+3 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Ended earlyNCT02855086
What this trial is testing

Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery

Who this might be right for
Brain NeoplasmMalignant Glioma
Eben Rosenthal 3
Early research (Phase 1)Study completedNCT00063973
What this trial is testing

Cilengitide in Treating Children With Refractory Primary Brain Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+23 more
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT00002569
What this trial is testing

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 299
Testing effectiveness (Phase 2)Study completedNCT00047294
What this trial is testing

Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00107003
What this trial is testing

GW572016 to Treat Recurrent Malignant Brain Tumors

Who this might be right for
GliomaBrain TumorGlioblastoma Multiforme+3 more
National Cancer Institute (NCI) 9
Not applicableStudy completedNCT00201903
What this trial is testing

The Roles of Tissue Factor in Malignant Gliomas

Who this might be right for
Venous ThromboembolismBrain Tumors
Ontario Clinical Oncology Group (OCOG) 30
Not applicableUnknownNCT06499922
What this trial is testing

Surgical Management of Low Grade Glioma

Who this might be right for
Low Grade Glioma of Brain
Assiut University 100
Testing effectiveness (Phase 2)Ended earlyNCT02624388
What this trial is testing

Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)

Who this might be right for
LymphomaChildhood LymphomaSolid Tumor+13 more
University of Virginia 4
Testing effectiveness (Phase 2)Ended earlyNCT03352427
What this trial is testing

Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations

Who this might be right for
GliomaHigh Grade GliomaPontine Tumors
University of Michigan Rogel Cancer Center 3
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Not applicableStudy completedNCT02023346
What this trial is testing

Prognostic Awareness and Patient-Physician Communication in Malignant Glioma

Who this might be right for
Malignant Glioma
Memorial Sloan Kettering Cancer Center 95
Not applicableStudy completedNCT01240161
What this trial is testing

Personalized Translational Platform for Biomarker Discovery in Brain Tumors

Who this might be right for
High Grade Glioma
Marcelo F. Di Carli, MD, FACC 37
Testing effectiveness (Phase 2)Study completedNCT00400816
What this trial is testing

Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma

Who this might be right for
Central Nervous System TumorsBrain Tumor
The Cleveland Clinic 29
Not applicableUnknownNCT02876016
What this trial is testing

Cerebral Bases Bodily Representations

Who this might be right for
Glial Tumors
Assistance Publique Hopitaux De Marseille 20
Testing effectiveness (Phase 2)Study completedNCT00379080
What this trial is testing

Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Brain TumorAdult Giant Cell GlioblastomaAdult Glioblastoma+2 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Early research (Phase 1)UnknownNCT00003842
What this trial is testing

IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Barrett Cancer Center 30
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Next Page